NPS Pharmaceuticals, Inc. (NASDAQ:NPSP)
| CAPS Rating |
|
|---|---|
| Open | $7.69 |
| Previous Close | $7.72 |
| Daily Range | $7.36 - $7.70 |
| 52-Week Range | $4.35 - $10.75 |
| Market Cap | $637.54M |
| P/E Ratio | 0.00 |
| Dividend (Yield) | N/A (N/A) |
| Volume | 719,267 |
| Average Daily Volume | 0 |
How do you think NPSP will perform against the market?
Caps
Motley Fool CAPS is a community working together to find better stocks and to become better investors.
NPSP Advanced Details
- CAPS Community Analysis: Commentary, Scorecard
- Advanced Financial Analysis: Historical Prices, Chart, Stats, Ratios, Earnings/Growth Rates, Statements, SEC Filings
NPSP News and Commentary
- Columbia Labs Fails to Impress FDA – Blogs @ The Motley Fool
- Rare Disease Drug Maker NPS Pharmaceuticals Looks Undervalued – Minyanville
- Is NPS Pharmaceuticals Hiding Weakness? – The Motley Fool
- NPS Pharmaceuticals Popped: What You Need to Know – The Motley Fool
- Top 6 Stocks for June – NASDAQ
- NPS Pharmaceuticals Shares Popped: What You Need to Know – The Motley Fool
- A Dedication to R&D Means These Stocks Could See Robust Growth – SeekingAlpha
- Squeeze Ideas: 20 Biotech Stocks Targeted by Short Sellers – SeekingAlpha
- NPS Pharmaceuticals Shares Plunged: What You Need to Know – The Motley Fool
- Top 30 Most Undervalued Small Cap Stocks by Analyst Target Price – SeekingAlpha
- NPS Pharma's Stock Price Is Getting Ahead of Company Value – SeekingAlpha
- NPS Pharmaceuticals Shares Popped: What You Need to Know – The Motley Fool
- Going Long on NPS Pharmaceuticals Through Options – SeekingAlpha
- Biotech’s Top and Bottom 10 From 2010 – SeekingAlpha
- Top 20 Oversold Stocks Being Bought by Smart Money – SeekingAlpha
- NPSP Pharmaceuticals CEO Discusses Q3 2010 - Earnings Call Transcript – SeekingAlpha
- NPSP Pharmaceuticals CEO Discusses Q3 2010 - Earnings Call Transcript – SeekingAlpha Transcripts
- Private Biotechs Take Different Avenues to Rake in Cash – SeekingAlpha
- Secondary-Offering Price Draws Market Price Like a Magnet – SeekingAlpha
- Smart Money's Top 9 Biotech Picks – SeekingAlpha

RSS Headlines
Fool UK